Norgestimate And Ethinyl Estradiol Kit
Product Images NDC 79929-008
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Norgestimate And Ethinyl Estradiol (NDC 79929-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Naari Pte Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chart (Chart)
This text describes the different rates of pregnancy per 100 women in one year based on the method of birth control used. It also lists the different birth control methods such as implants, injections, intrauterine devices, sterilization, birth control pills, patches, vaginal rings with hormones, condoms, diaphragms, spermicides, withdrawal, and no birth control. The text provides information on how different methods can result in either fewer or more pregnancies.*
Figure (Figure)
This text appears to be a list of various studies related to women's contraceptive use, with some indication of the year of the study and whether it looked at past or current contraceptive use. There are also some numerical values given, which may be effect estimates, but it is difficult to know for sure without additional information.*
Flow (Flow)
Structure (Structure)
Ethinyl Estradiol is a synthetic derivative of the naturally occurring female hormone, estradiol. It is commonly used in combination with progestin as a hormonal contraceptive to prevent pregnancy. Ethinyl Estradiol works by suppressing ovulation and altering cervical mucus, making it difficult for sperm to reach and fertilize an egg.*
Table (Table)
The text provides instructions on what to do when one or two active tablets of Norgestimate and Ethinyl Estradiol Tablets USP are missed during Weeks 1, 2, or 3. It also provides guidance on what to do if three or more tablets are missed in a row during Weeks 1, 2, or 3. The instructions include when to take missed tablets, when to start a new pack, and when to use additional non-hormonal contraception as a back-up.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.